MAX | Agilis Health

In a rapidly evolving healthcare landscape, Medical Affairs must lead with purpose; turning scientific insight into measurable impact through responsible innovation. The Medical Affairs eXcellence Forum brings together forward-thinking Medical Affairs leaders and field teams to explore what’s working now; from governed AI and real-world evidence to modern stakeholder engagement and next-generation MSL strategy.

This exclusive, one-day forum is designed for Medical Affairs professionals who are ready to move beyond pilots and traditional activity metrics; embracing leadership-driven innovation to elevate scientific exchange, strengthen trust with HCPs, and deliver real-world impact for patients, providers, and the healthcare system.

CLICK HERE TO REGISTER

MARCH 25, 2026 | TORONTO, ON

Sheraton Toronto Airport (801 Dixon Road, Toronto)

Download Program Overview

Sponsorship Opportunities Available!

Click Here to Request Sponsor Prospectus

Why Attend?

Turn AI & RWE into measurable impact
Hear what’s working from Medical Affairs leaders
Explore next-gen stakeholder engagement & MSL strategy
Network with a curated Canadian Medical Affairs community

Target Audience

Medical Affairs Leaders: VP/Head Medical Affairs, Country Medical Directors, Head of Medical Excellence/Operations, Head of Pharmacovigilance, Head of Evidence Generation / HEOR, Head/Director Medical Communications
Therapeutic Areas Leaders: TA Medical Directors, Associate Medical Directors, Medical Leads, Medical Managers, Medical Advisors
Field Based Medical Affairs: Medical Science Liaisons, Sr Medical Science Liaisons, Field Medical Education Manager, MSL Managers/Directors
Clinical & RWE Strategists: Medical Science Liaisons, Sr Medical Science Liaisons, Field Medical Education Manager, MSL Managers/Directors
Biopharma Cross Functional Team: Professionals and leaders across Marketing, Sales, Market Access, Compliance and others

Agenda

Subject to Change

Jefferson Tea is currently the Founder & CEO at Agilis Health Inc., a Consulting Firm focused on strategic consulting and knowledge transfer in the biopharmaceutical and life science sector.

He has over 27 years of experience in the biopharmaceutical industry in Research & Development, Medical Affairs, Marketing & Sales, Patient Services and Market Access.

Until the end of 2024, Dr. Tea was previously Vice-President Medical, PSP & Regulatory Affairs at Takeda Canada for 12 years, and has held other leadership roles at Amgen, AstraZeneca and Pfizer at the Canadian and Global levels.

Dr. Tea holds a PhD in pharmacology and an MBA from the University of Montreal. In addition, he has completed C-Suite Level Advanced Leadership training programs from Rotman Business School (University of Toronto), AdMare BioInnovations Executive Institute (Vancouver, BC) and Columbia University Executive Institute (New-York, NY). Finally, he was on the Board of Directors of CATALIS (non-for-profit organization to optimize clinical research), Advisor for CDA (Canadian Drug Agency), PAAB (Pharmaceutical Advertising Advisory Board) and University of Toronto Rotman Business School. He is currently an Advisor of the Start-Up Accelerator Program at MaRS.